Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Nov;71(11):8798–8807. doi: 10.1128/jvi.71.11.8798-8807.1997

The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.

A Lieber 1, C Y He 1, L Meuse 1, D Schowalter 1, I Kirillova 1, B Winther 1, M A Kay 1
PMCID: PMC192346  PMID: 9343240

Abstract

Systemic application of first-generation adenovirus induces pathogenic effects in the liver. To begin unraveling the mechanisms underlying early liver toxicity after adenovirus infusion, particularly the role of macrophage activation and expression of viral genes in transduced target cells, first-generation adenovirus or adenovirus vectors that lacked most early and late gene expression were administered to C3H/HeJ mice after transient depletion of Kupffer cells by gadolinium chloride treatment. Activation of NF-kappaB, and the serum levels of the proinflammatory cytokines tumor necrosis factor (TNF) and interleukin-6 (IL-6) were studied in correlation with liver damage, apoptosis, and hepatocellular DNA synthesis. While Kupffer cell depletion nearly eliminated adenovirus-induced TNF release, it resulted in a more robust IL-6 release. These responses were greatly reduced in animals receiving the deleted adenovirus. Although there were quantitative differences, NF-kappaB activation was observed within minutes of first-generation or deleted adenovirus vector administration regardless of the status of the Kupffer cells, suggesting that the induction is related to a direct effect of the virus particle on the hepatocyte. Early liver toxicity as determined by serum glutamic-pyruvic transaminase elevation and inflammatory cell infiltrates appeared to be dependent on adenovirus-mediated early gene expression and intact Kupffer cell function. Kupffer cell depletion had little effect on adenovirus-mediated hepatocyte apoptosis but did increase hepatocellular DNA synthesis. Finally, Kupffer cell depletion decreased the persistence of transgene (human alpha1-antitrypsin [hAAT]) expression that was associated with a more pronounced humoral immune response against hAAT. The elucidation of these events occurring after intravenous adenovirus injection will be important in developing new vectors and transfer techniques with reduced toxicity.

Full Text

The Full Text of this article is available as a PDF (2.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andus T., Bauer J., Gerok W. Effects of cytokines on the liver. Hepatology. 1991 Feb;13(2):364–375. [PubMed] [Google Scholar]
  2. Baeuerle P. A., Baltimore D. NF-kappa B: ten years after. Cell. 1996 Oct 4;87(1):13–20. doi: 10.1016/s0092-8674(00)81318-5. [DOI] [PubMed] [Google Scholar]
  3. Barr D., Tubb J., Ferguson D., Scaria A., Lieber A., Wilson C., Perkins J., Kay M. A. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 1995 Mar;2(2):151–155. [PubMed] [Google Scholar]
  4. Bett A. J., Haddara W., Prevec L., Graham F. L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8802–8806. doi: 10.1073/pnas.91.19.8802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boucher R. C. Current status of CF gene therapy. Trends Genet. 1996 Mar;12(3):81–84. doi: 10.1016/0168-9525(96)81410-7. [DOI] [PubMed] [Google Scholar]
  6. Bruder J. T., Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol. 1997 Jan;71(1):398–404. doi: 10.1128/jvi.71.1.398-404.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Busam K. J., Homfeld A., Zawatzky R., Kästner S., Bauer J., Gerok W., Decker K. Virus-vs endotoxin-induced activation of liver macrophages. Eur J Biochem. 1990 Aug 17;191(3):577–582. doi: 10.1111/j.1432-1033.1990.tb19160.x. [DOI] [PubMed] [Google Scholar]
  8. Callery M. P., Kamei T., Flye M. W. Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch Surg. 1990 Jan;125(1):36–41. doi: 10.1001/archsurg.1990.01410130038005. [DOI] [PubMed] [Google Scholar]
  9. Cornell R. P., Liljequist B. L., Bartizal K. F. Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology. 1990 Jun;11(6):916–922. doi: 10.1002/hep.1840110603. [DOI] [PubMed] [Google Scholar]
  10. Cornell R. P. Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration. Am J Physiol. 1985 Nov;249(5 Pt 2):R563–R569. doi: 10.1152/ajpregu.1985.249.5.R563. [DOI] [PubMed] [Google Scholar]
  11. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 1990 Sep 11;192(2):245–261. doi: 10.1111/j.1432-1033.1990.tb19222.x. [DOI] [PubMed] [Google Scholar]
  12. Deryckere F., Burgert H. G. Tumor necrosis factor alpha induces the adenovirus early 3 promoter by activation of NF-kappaB. J Biol Chem. 1996 Nov 22;271(47):30249–30255. doi: 10.1074/jbc.271.47.30249. [DOI] [PubMed] [Google Scholar]
  13. FitzGerald M. J., Webber E. M., Donovan J. R., Fausto N. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ. 1995 Apr;6(4):417–427. [PubMed] [Google Scholar]
  14. Ginsberg H. S., Lundholm-Beauchamp U., Horswood R. L., Pernis B., Wold W. S., Chanock R. M., Prince G. A. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci U S A. 1989 May;86(10):3823–3827. doi: 10.1073/pnas.86.10.3823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ginsberg H. S., Moldawer L. L., Sehgal P. B., Redington M., Kilian P. L., Chanock R. M., Prince G. A. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1651–1655. doi: 10.1073/pnas.88.5.1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ginsberg H. S. The ups and downs of adenovirus vectors. Bull N Y Acad Med. 1996 Summer;73(1):53–58. [PMC free article] [PubMed] [Google Scholar]
  17. Gooding L. R. Regulation of TNF-mediated cell death and inflammation by human adenoviruses. Infect Agents Dis. 1994 Apr-Jun;3(2-3):106–115. [PubMed] [Google Scholar]
  18. Hardonk M. J., Dijkhuis F. W., Hulstaert C. E., Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol. 1992 Sep;52(3):296–302. doi: 10.1002/jlb.52.3.296. [DOI] [PubMed] [Google Scholar]
  19. Ilan Y., Droguett G., Chowdhury N. R., Li Y., Sengupta K., Thummala N. R., Davidson A., Chowdhury J. R., Horwitz M. S. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2587–2592. doi: 10.1073/pnas.94.6.2587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ishiyama H., Sato M., Matsumura K., Sento M., Ogino K., Hobara T. Proliferation of hepatocytes and attenuation from carbon tetrachloride hepatotoxicity by gadolinium chloride in rats. Pharmacol Toxicol. 1995 Oct;77(4):293–298. doi: 10.1111/j.1600-0773.1995.tb01030.x. [DOI] [PubMed] [Google Scholar]
  21. Kay M. A., Baley P., Rothenberg S., Leland F., Fleming L., Ponder K. P., Liu T., Finegold M., Darlington G., Pokorny W. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):89–93. doi: 10.1073/pnas.89.1.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kay M. A., Graham F., Leland F., Woo S. L. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology. 1995 Mar;21(3):815–819. [PubMed] [Google Scholar]
  23. Kay M. A., Holterman A. X., Meuse L., Gown A., Ochs H. D., Linsley P. S., Wilson C. B. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet. 1995 Oct;11(2):191–197. doi: 10.1038/ng1095-191. [DOI] [PubMed] [Google Scholar]
  24. Kay M. A., Li Q., Liu T. J., Leland F., Toman C., Finegold M., Woo S. L. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther. 1992 Dec;3(6):641–647. doi: 10.1089/hum.1992.3.6-641. [DOI] [PubMed] [Google Scholar]
  25. Kolls J., Peppel K., Silva M., Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):215–219. doi: 10.1073/pnas.91.1.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kuzmin A. I., Finegold M. J., Eisensmith R. C. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Ther. 1997 Apr;4(4):309–316. doi: 10.1038/sj.gt.3300377. [DOI] [PubMed] [Google Scholar]
  27. Li Q., Kay M. A., Finegold M., Stratford-Perricaudet L. D., Woo S. L. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther. 1993 Aug;4(4):403–409. doi: 10.1089/hum.1993.4.4-403. [DOI] [PubMed] [Google Scholar]
  28. Lieber A., He C. Y., Kirillova I., Kay M. A. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol. 1996 Dec;70(12):8944–8960. doi: 10.1128/jvi.70.12.8944-8960.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lieber A., Vrancken Peeters M. J., Meuse L., Fausto N., Perkins J., Kay M. A. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6210–6214. doi: 10.1073/pnas.92.13.6210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Marianneau P., Cardona A., Edelman L., Deubel V., Desprès P. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol. 1997 Apr;71(4):3244–3249. doi: 10.1128/jvi.71.4.3244-3249.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Noah T. L., Wortman I. A., Hu P. C., Leigh M. W., Boucher R. C. Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5. Am J Respir Cell Mol Biol. 1996 May;14(5):417–424. doi: 10.1165/ajrcmb.14.5.8624246. [DOI] [PubMed] [Google Scholar]
  32. Pessara U., Koch N. Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-kappa B-like factor to a promoter element. Mol Cell Biol. 1990 Aug;10(8):4146–4154. doi: 10.1128/mcb.10.8.4146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pfizenmaier K., Wajant H., Grell M. Tumor necrosis factors in 1996. Cytokine Growth Factor Rev. 1996 Oct;7(3):271–277. doi: 10.1016/s1359-6101(96)00028-7. [DOI] [PubMed] [Google Scholar]
  34. Rai R. M., Yang S. Q., McClain C., Karp C. L., Klein A. S., Diehl A. M. Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. Am J Physiol. 1996 Jun;270(6 Pt 1):G909–G918. doi: 10.1152/ajpgi.1996.270.6.G909. [DOI] [PubMed] [Google Scholar]
  35. Salkowski C. A., Neta R., Wynn T. A., Strassmann G., van Rooijen N., Vogel S. N. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J Immunol. 1995 Sep 15;155(6):3168–3179. [PubMed] [Google Scholar]
  36. Sambucetti L. C., Cherrington J. M., Wilkinson G. W., Mocarski E. S. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989 Dec 20;8(13):4251–4258. doi: 10.1002/j.1460-2075.1989.tb08610.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schowalter D. B., Meuse L., Wilson C. B., Linsley P. S., Kay M. A. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression. Gene Ther. 1997 Aug;4(8):853–860. doi: 10.1038/sj.gt.3300466. [DOI] [PubMed] [Google Scholar]
  38. Shimizu H., Mitomo K., Watanabe T., Okamoto S., Yamamoto K. Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol. 1990 Feb;10(2):561–568. doi: 10.1128/mcb.10.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Shiratori Y., Hongo S., Hikiba Y., Ohmura K., Nagura T., Okano K., Kamii K., Tanaka T., Komatsu Y., Ochiai T. Role of macrophages in regeneration of liver. Dig Dis Sci. 1996 Oct;41(10):1939–1946. doi: 10.1007/BF02093593. [DOI] [PubMed] [Google Scholar]
  40. Sparer T. E., Tripp R. A., Dillehay D. L., Hermiston T. W., Wold W. S., Gooding L. R. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J Virol. 1996 Apr;70(4):2431–2439. doi: 10.1128/jvi.70.4.2431-2439.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Teodoro J. G., Branton P. E. Regulation of apoptosis by viral gene products. J Virol. 1997 Mar;71(3):1739–1746. doi: 10.1128/jvi.71.3.1739-1746.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tsui L. V., Guidotti L. G., Ishikawa T., Chisari F. V. Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12398–12402. doi: 10.1073/pnas.92.26.12398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Vidal S. M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 1993 May 7;73(3):469–485. doi: 10.1016/0092-8674(93)90135-d. [DOI] [PubMed] [Google Scholar]
  44. Vrancken Peeters M. J., Perkins A. L., Kay M. A. Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. Biotechniques. 1996 Feb;20(2):278–285. doi: 10.2144/96202rr05. [DOI] [PubMed] [Google Scholar]
  45. Watson J., Kelly K., Largen M., Taylor B. A. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol. 1978 Feb;120(2):422–424. [PubMed] [Google Scholar]
  46. Wold W. S. Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J Cell Biochem. 1993 Dec;53(4):329–335. doi: 10.1002/jcb.240530410. [DOI] [PubMed] [Google Scholar]
  47. Wolff G., Worgall S., van Rooijen N., Song W. R., Harvey B. G., Crystal R. G. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol. 1997 Jan;71(1):624–629. doi: 10.1128/jvi.71.1.624-629.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Worgall S., Wolff G., Falck-Pedersen E., Crystal R. G. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther. 1997 Jan 1;8(1):37–44. doi: 10.1089/hum.1997.8.1-37. [DOI] [PubMed] [Google Scholar]
  49. Wrighton C. J., Hofer-Warbinek R., Moll T., Eytner R., Bach F. H., de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med. 1996 Mar 1;183(3):1013–1022. doi: 10.1084/jem.183.3.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yamada Y., Kirillova I., Peschon J. J., Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1441–1446. doi: 10.1073/pnas.94.4.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yang Y., Nunes F. A., Berencsi K., Furth E. E., Gönczöl E., Wilson J. M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4407–4411. doi: 10.1073/pnas.91.10.4407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yang Y., Nunes F. A., Berencsi K., Gönczöl E., Engelhardt J. F., Wilson J. M. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet. 1994 Jul;7(3):362–369. doi: 10.1038/ng0794-362. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES